https://seekingalpha.com/news/4045689-jnj-multiple-myeloma-therapy-outperforms-standard-of-care?source=feed_sector_healthcare
Dec 12, 2023 - Johnson & Johnson's (JNJ) multiple myeloma therapy Darzalex Faspro in combination with traditional treatments outperforms standard of care. Read more here.
0
sa:-3076942884654145356
0
https://seekingalpha.com/news/4056938-jnj-looking-to-move-talc-powder-unit-to-texas-ahead-of-bankruptcy-filing-report?source=feed_sector_healthcare
Jan 22, 2024 - Johnson & Johnson (JNJ) is reportedly looking to relocate its LTL talc powder unit to Texas ahead of an expected third bankruptcy filing for the subsidiary. Read more here.
0
sa:-6988141442641183309
0
https://www.fool.com/earnings/call-transcripts/2024/01/23/johnson-johnson-jnj-q4-2023-earnings-call-transcri/?source=iedfolrf0000001
Jan 23, 2024 - JNJ earnings call for the period ending December 31, 2023.
0
fool:-5756587576249076656
0
https://www.fool.com/investing/2024/02/03/7-dividend-stocks-that-pay-me-more-than-500-per-mo/?source=iedfolrf0000001
Feb 03, 2024 - These stocks pay safe, reliable, and growing dividends.
0
fool:-8143902548400009636
0
https://seekingalpha.com/news/4050710-can-jnj-reverse-loss-in-2024-on-eps-growth-eyes-on-talc-litigation?source=feed_sector_healthcare
Dec 27, 2023 - Johnson & Johnson 2024: What to Expect Wells Fargo downgraded Johnson & Johnson (JNJ) to equal weight and lowered PT to $163 from $170 as analyst expects EPS gr
0
sa:-7542181225205457092
0
https://www.fool.com/investing/2023/12/29/there-are-only-5-dow-stocks-i-wouldnt-buy-in-2024/?source=iedfolrf0000001
Dec 29, 2023 - There's a lot to like about Apple, Microsoft, and most of the Dow Jones Industrial Average components in 2024.
0
fool:-8481294172515244912
0
https://www.fool.com/investing/2023/12/30/2-best-warren-buffett-stocks-to-buy-for-the-long/?source=iedfolrf0000001
Dec 30, 2023 - These companies need no introduction.
0
fool:-2195405370003413174
0
https://www.fool.com/investing/2024/02/17/3-unstoppable-dividend-stocks-that-could-pay-you-f/?source=iedfolrf0000001
Feb 17, 2024 - There are no certainties in life or on the stock market. These companies' dividends are about as close as we can get.
0
fool:5561653441260339128
0
https://www.fool.com/investing/2024/03/16/magnificent-seven-stock-pays-most-dividends/?source=iedfolrf0000001
Mar 16, 2024 - Microsoft is the complete package.
0
fool:-5058767896321207201
0
https://www.zacks.com/stock/news/2193151/lilly-lly-gets-second-fda-nod-for-lymphoma-drug-jaypirca?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193151
Dec 04, 2023 - Following the latest approval, Lilly's (LLY) Jaypirca is the first and the only non-covalent BTK inhibitor to extend the benefit of targeting the BTK pathway.
zc:964429687094150899
0